Acumen Pharmaceuticals GAAP EPS of -$0.68 misses by $0.16

4 hours ago 1

Acumen Pharmaceuticals press release (NASDAQ:ABOS): Q2 GAAP EPS of -$0.68 misses by $0.16.
Cash, cash equivalents and marketable securities of $166.2 million as of June 30, 2025, expected to support current clinical and operational activities into early 2027

Recommended For You